TCM
Tang Capital Management Portfolio holdings
AUM
$2.6B
1-Year Est. Return
43.55%
1 Year Est. Return
+43.55%
AUM
$1.98B
AUM Growth
+$171M
(+9.4%)
Holding
220
Top Buys
| 1 | +$28.3M | |
| 2 | +$26.3M | |
| 3 | +$22.9M | |
| 4 |
Boeing
BA
|
+$20.9M |
| 5 |
Spyre Therapeutics
SYRE
|
+$17.2M |
Top Sells
| 1 | +$37.7M | |
| 2 | +$29M | |
| 3 | +$24.3M | |
| 4 |
ONC
BeOne Medicines Ltd
ONC
|
+$10.1M |
| 5 |
CRISPR Therapeutics
CRSP
|
+$9.07M |
Sector Composition
| 1 | Healthcare | 94.16% |
| 2 | Technology | 1.37% |
| 3 | Industrials | 1.32% |
| 4 | Communication Services | 1.26% |
| 5 | Consumer Discretionary | 0.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Microsoft
MSFT
$3.79T
| $1.76M | 0.09% |
3,546
-1,279
|
|
||
127
Visa
V
$637B
| $1.73M | 0.09% |
4,869
-1,701
|
|
||
128
Walmart
WMT
$817B
| $1.69M | 0.09% |
17,242
-6,560
|
|
||
129
Coca-Cola
KO
$306B
| $1.61M | 0.08% |
22,712
-7,050
|
|
||
130
Berkshire Hathaway Class B
BRK.B
$1.1T
| $1.58M | 0.08% |
3,250
-1,151
|
|
||
131
Verizon
VZ
$173B
| $1.57M | 0.08% |
36,266
-10,887
|
|
||
132
Texas Instruments
TXN
$145B
| $1.54M | 0.08% |
7,415
-2,360
|
|
||
133
Intel
INTC
$169B
| $1.48M | 0.08% |
66,216
-18,729
|
|
||
134
Netflix
NFLX
$471B
| $1.46M | 0.07% |
1,089
-212
|
|
||
135
Johnson & Johnson
JNJ
$472B
| $1.45M | 0.07% |
9,472
-2,771
|
|
||
136
Procter & Gamble
PG
$345B
| $1.43M | 0.07% |
8,952
-2,861
|
|
||
137
Nike
NKE
$94.9B
| $1.38M | 0.07% |
19,399
-5,365
|
|
||
138
Exxon Mobil
XOM
$503B
| $1.36M | 0.07% |
12,651
-3,946
|
|
||
139
OptimizeRx
OPRX
$283M
| $1.35M | 0.07% |
100,000
|
|
||
140
Home Depot
HD
$361B
| $1.34M | 0.07% |
3,646
-1,204
|
|
||
141
ALX Oncology
ALXO
$74.8M
| $1.31M | 0.07% |
3,158,265
|
|
||
142
PayPal
PYPL
$58.8B
| $1.29M | 0.07% |
17,323
-4,785
|
|
||
143
C4 Therapeutics
CCCC
$239M
| $1.29M | 0.07% |
900,000
|
|
||
144
Pfizer
PFE
$142B
| $1.29M | 0.07% |
53,039
-13,761
|
|
||
145
GE Aerospace
GE
$322B
| $1.28M | 0.06% |
4,986
-689
|
|
||
146
GE Vernova
GEV
$157B
| $1.28M | 0.06% |
2,421
-172
|
|
||
|
CLYM
147
Climb Bio
CLYM
$130M
| $1.24M | 0.06% |
1,000,000
|
|
||
148
Viatris
VTRS
$12.3B
| $1.15M | 0.06% |
128,359
-40,620
|
|
||
149
Ulta Beauty
ULTA
$23.7B
| $1.13M | 0.06% |
2,410
-196
|
|
||
150
Verastem
VSTM
$504M
| $1.12M | 0.06% |
270,000
|
|